Colgate Passes Again On Offering Earnings Guidance Due To Market ‘Complexity, Volatility’
Executive Summary
Colgate won’t provide full-year 2020 guidance even as the company reports 5.5% organic growth in the second quarter. Its sales in North America grew 24% on pandemic-related purchasing and price increases.
You may also be interested in...
Prestige Consumer’s Diverse Lineup Buoys Results As Pandemic Causes Slumps In Some Categories
Prestige Consumer Healthcare says pandemic-caused sales slump for many of its OTC drug products was offset somewhat by strong sales of brands including Dentek, Monistat and Summer’s Eve, which were boosted by targeted advertising and promotions.
Church & Dwight’s Consumer Health Product Sales Spared From Pandemic Plummet In Q2
C&D said sales of its brands including vitafusion, L’il Critters and PB8 supplements, Arm & Hammer, Aim and Close-Up toothpastes and Waterpick and Spinbrush power toothbrushes helped drive 8.8% growth to $386.4m for the personal and health care categories.
After 5% Sales Growth In Its FY 2020, P&G Bullish For 2021 Despite Looming Economic Threats
Macro factors that could hamper results include the economic recession caused by businesses’ reactions to novel coronavirus pandemic, the impact of COVID-19 on consumer buying trends and disruptions to supply chains.